nach oben

Angiogenesis

Erschienen in:

01.04.2013 | Review Paper

PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow

verfasst von: Hakan Orbay, Hao Hong, Yin Zhang, Weibo Cai

Erschienen in: Angiogenesis | Ausgabe 2/2013

Einloggen, um Zugang zu erhalten

Abstract

Peripheral artery disease (PAD) is a result of the atherosclerotic narrowing of blood vessels to the extremities, and the subsequent tissue ischemia can lead to the up-regulation of angiogenic growth factors and formation of new vessels as a recovery mechanism. Such formation of new vessels can be evaluated with various non-invasive molecular imaging techniques, where serial images from the same subjects can be obtained to allow the documentation of disease progression and therapeutic response. The most commonly used animal model for preclinical studies of PAD is the murine hindlimb ischemia model, and a number of radiotracers have been investigated for positron emission tomography (PET) and single photon emission computed tomography (SPECT) imaging of PAD. In this review article, we summarize the PET/SPECT tracers that have been tested in the murine hindlimb ischemia model as well as those used clinically to assess the extremity blood flow.

Sumner AD, Khalil YK, Reed JF 3rd (2012) The relationship of peripheral arterial disease and metabolic syndrome prevalence in asymptomatic US adults 40 years and older: results from the National Health and Nutrition Examination Survey (1999–2004). J Clin Hypertens (Greenwich) 14:144–148CrossRef

van Weel V, van Tongeren RB, van Hinsbergh VW, van Bockel JH, Quax PH (2008) Vascular growth in ischemic limbs: a review of mechanisms and possible therapeutic stimulation. Ann Vasc Surg 22:582–597PubMedCrossRef

Clair D, Shah S, Weber J (2012) Current state of diagnosis and management of critical limb ischemia. Curr Cardiol Rep 14:160–170PubMedCrossRef

Hinchliffe RJ, Andros G, Apelqvist J, Bakker K, Friederichs S, Lammer J et al (2012) A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes and peripheral arterial disease. Diabetes Metab Res Rev 28(Suppl 1):179–217PubMedCrossRef

Ouriel K (2001) Peripheral arterial disease. Lancet 358:1257–1264PubMedCrossRef

Andersen CA (2010) Noninvasive assessment of lower extremity hemodynamics in individuals with diabetes mellitus. J Vasc Surg 52:76S–80SPubMedCrossRef

Mathieu D, Mani R (2007) A review of the clinical significance of tissue hypoxia measurements in lower extremity wound management. Int J Low Extrem Wounds 6:273–283PubMedCrossRef

Tang GL, Chin J, Kibbe MR (2010) Advances in diagnostic imaging for peripheral arterial disease. Expert Rev Cardiovasc Ther 8:1447–1455PubMedCrossRef

Galbraith JE, Murphy ML, de Soyza N (1978) Coronary angiogram interpretation. Interobserver variability. JAMA 240:2053–2056PubMedCrossRef

10.

Leape LL, Park RE, Bashore TM, Harrison JK, Davidson CJ, Brook RH (2000) Effect of variability in the interpretation of coronary angiograms on the appropriateness of use of coronary revascularization procedures. Am Heart J 139:106–113PubMedCrossRef

11.

Cavalcanti Filho JL, de Souza Leao Lima R, de Souza Machado Neto L, Kayat Bittencourt L, Domingues RC, da Fonseca LM (2011) PET/CT and vascular disease: current concepts. Eur J Radiol 80:60–67PubMedCrossRef

12.

Dobrucki LW, Sinusas AJ (2007) Imaging angiogenesis. Curr Opin Biotechnol 18:90–96PubMedCrossRef

13.

Suh JW, Scheinost D, Dione DP, Dobrucki LW, Sinusas AJ, Papademetris X (2011) A non-rigid registration method for serial lower extremity hybrid SPECT/CT imaging. Med Image Anal 15:96–111PubMedCrossRef

14.

Cai W, Chen X (2007) Multimodality imaging of vascular endothelial growth factor and vascular endothelial growth factor receptor expression. Front Biosci 12:4267–4279PubMedCrossRef

15.

Cai W, Chen X (2008) Multimodality molecular imaging of tumor angiogenesis. J Nucl Med 49(Suppl 2):113S–128SPubMedCrossRef

16.

Waters RE, Terjung RL, Peters KG, Annex BH (2004) Preclinical models of human peripheral arterial occlusive disease: implications for investigation of therapeutic agents. J Appl Physiol 97:773–780PubMedCrossRef

17.

Couffinhal T, Silver M, Zheng LP, Kearney M, Witzenbichler B, Isner JM (1998) Mouse model of angiogenesis. Am J Pathol 152:1667–1679PubMed

18.

Niiyama H, Huang NF, Rollins MD, Cooke JP (2009) Murine model of hindlimb ischemia. J Vis Exp 23:1035. doi:10.3791/1035

19.

James ML, Gambhir SS (2012) A molecular imaging primer: modalities, imaging agents, and applications. Physiol Rev 92:897–965PubMedCrossRef

20.

Ubbink DT, Tulevski II, den Hartog D, Koelemay MJ, Legemate DA, Jacobs MJ (1997) The value of non-invasive techniques for the assessment of critical limb ischaemia. Eur J Vasc Endovasc Surg 13:296–300PubMedCrossRef

21.

Alauddin MM (2012) Positron emission tomography (PET) imaging with ¹⁸F-based radiotracers. Am J Nucl Med Mol Imaging 2:55–76PubMed

22.

Vach W, Høilund-Carlsen PF, Fischer BM, Gerke O, Weber W (2011) How to study optimal timing of PET/CT for monitoring of cancer treatment. Am J Nucl Med Mol Imaging 1:54–62PubMed

23.

Zeman MN, Scott PJH (2012) Current imaging strategies in rheumatoid arthritis. Am J Nucl Med Mol Imaging 2:174–220PubMed

24.

Bhargava P, He G, Samarghandi A, Delpassand ES (2012) Pictorial review of SPECT/CT imaging applications in clinical nuclear medicine. Am J Nucl Med Mol Imaging 2:221–231PubMed

25.

Ogasawara Y, Ogasawara K, Suzuki T, Yamashita T, Kuroda H, Chida K et al (2012) Preoperative ¹²³I-iomazenil SPECT imaging predicts cerebral hyperperfusion following endarterectomy for unilateral cervical internal carotid artery stenosis. Am J Nucl Med Mol Imaging 2:77–87PubMed

26.

Stacy MR, Maxfield MW, Sinusas AJ (2012) Targeted molecular imaging of angiogenesis in PET and SPECT: a review. Yale J Biol Med 85:75–86PubMed

27.

Gambhir SS, Czernin J, Schwimmer J, Silverman DH, Coleman RE, Phelps ME (2001) A tabulated summary of the FDG PET literature. J Nucl Med 42:1S–93SPubMed

28.

Aparici CM, Carlson D, Nguyen N, Hawkins RA, Seo Y (2012) Combined SPECT and multidetector CT for prostate cancer evaluations. Am J Nucl Med Mol Imaging 2:48–54PubMed

29.

Eary JF, Hawkins DS, Rodler ET, Conrad EUI (2011) ¹⁸F-FDG PET in sarcoma treatment response imaging. Am J Nucl Med Mol Imaging 1:47–53PubMed

30.

Gambhir SS (2002) Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2:683–693PubMedCrossRef

31.

Grassi I, Nanni C, Allegri V, Morigi JJ, Montini GC, Castellucci P et al (2012) The clinical use of PET with ¹¹C-acetate. Am J Nucl Med Mol Imaging 2:33–47PubMed

32.

Zhao R, Wang J, Deng J, Yang W, Wang J (2012) Efficacy of ^99mTc-EDDA/HYNIC-TOC SPECT/CT scintigraphy in Graves’ ophthalmopathy. Am J Nucl Med Mol Imaging 2:242–247PubMed

33.

Cai W, Rao J, Gambhir SS, Chen X (2006) How molecular imaging is speeding up anti-angiogenic drug development. Mol Cancer Ther 5:2624–2633PubMedCrossRef

34.

Hao G, Hajibeigi A, De León-Rodríguez LM, Öz OK, Sun X (2011) Peptoid-based PET imaging of vascular endothelial growth factor receptor (VEGFR) expression. Am J Nucl Med Mol Imaging 1:65–75PubMed

35.

Wang RE, Niu Y, Wu H, Amin MN, Cai J (2011) Development of NGR peptide-based agents for tumor imaging. Am J Nucl Med Mol Imaging 1:36–46PubMed

36.

Zhang Y, Hong H, Engle JW, Yang Y, Barnhart TE, Cai W (2012) Positron emission tomography and near-infrared fluorescence imaging of vascular endothelial growth factor with dual-labeled bevacizumab. Am J Nucl Med Mol Imaging 2:1–13PubMed

37.

Ferrara N (2004) Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 25:581–611PubMedCrossRef

38.

Ferrara N (2002) VEGF and the quest for tumour angiogenesis factors. Nat Rev Cancer 2:795–803PubMedCrossRef

39.

Cai W, Niu G, Chen X (2008) Imaging of integrins as biomarkers for tumor angiogenesis. Curr Pharm Des 14:2943–2973PubMedCrossRef

40.

Almutairi A, Rossin R, Shokeen M, Hagooly A, Ananth A, Capoccia B et al (2009) Biodegradable dendritic positron-emitting nanoprobes for the noninvasive imaging of angiogenesis. Proc Natl Acad Sci USA 106:685–690PubMedCrossRef

41.

Jeong JM, Hong MK, Chang YS, Lee YS, Kim YJ, Cheon GJ et al (2008) Preparation of a promising angiogenesis PET imaging agent: ⁶⁸Ga-labeled c(RGDyK)-isothiocyanatobenzyl-1,4,7-triazacyclononane-1,4,7-triacetic acid and feasibility studies in mice. J Nucl Med 49:830–836PubMedCrossRef

42.

Potter LR, Hunter T (2001) Guanylyl cyclase-linked natriuretic peptide receptors: structure and regulation. J Biol Chem 276:6057–6060PubMedCrossRef

43.

van den Akker F (2001) Structural insights into the ligand binding domains of membrane bound guanylyl cyclases and natriuretic peptide receptors. J Mol Biol 311:923–937PubMedCrossRef

44.

Liu Y, Pressly ED, Abendschein DR, Hawker CJ, Woodard GE, Woodard PK et al (2011) Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PET. J Nucl Med 52:1956–1963PubMedCrossRef

45.

Cai W, Hong H (2011) Peptoid and positron emission tomography: an appealing combination. Am J Nucl Med Mol Imaging 1:76–79PubMed

46.

Willmann JK, Chen K, Wang H, Paulmurugan R, Rollins M, Cai W et al (2008) Monitoring of the biological response to murine hindlimb ischemia with ⁶⁴Cu-labeled vascular endothelial growth factor-121 positron emission tomography. Circulation 117:915–922PubMedCrossRef

47.

Penuelas I, Aranguren XL, Abizanda G, Marti-Climent JM, Uriz M, Ecay M et al (2007) ¹³N-ammonia PET as a measurement of hindlimb perfusion in a mouse model of peripheral artery occlusive disease. J Nucl Med 48:1216–1223PubMedCrossRef

48.

Hua J, Dobrucki LW, Sadeghi MM, Zhang J, Bourke BN, Cavaliere P et al (2005) Noninvasive imaging of angiogenesis with a ^99mTc-labeled peptide targeted at alphavbeta3 integrin after murine hindlimb ischemia. Circulation 111:3255–3260PubMedCrossRef

49.

Dobrucki LW, Dione DP, Kalinowski L, Dione D, Mendizabal M, Yu J et al (2009) Serial noninvasive targeted imaging of peripheral angiogenesis: validation and application of a semiautomated quantitative approach. J Nucl Med 50:1356–1363PubMedCrossRef

50.

Depairon M, De Landsheere C, Merlo P, Del Fiore G, Quaglia L, Peters JM et al (1988) Effect of exercise on the leg distribution of C¹⁵O₂ and ¹⁵O₂ in normals and in patients with peripheral ischemia: a study using positron tomography. Int Angiol 7:254–257PubMed

51.

Depairon M, Depresseux JC, De Landsheere C, Merlo P, Del Fiore G, Quaglia L et al (1988) Regional blood flow and oxygen consumption in the leg muscles of normal subjects and in those with arterial insufficiency. Study of the distribution of C¹⁵O₂ and of ¹⁵O₂ using positron emission tomography. J Mal Vasc 13:107–115PubMed

52.

Keenan GF, Ashcroft GP, Roditi GH, Hutchison JD, Evans NT, Mikecz P et al (1995) Measurement of lower limb blood flow in patients with neurogenic claudication using positron emission tomography. Spine (Phila Pa 1976) 20:408–411CrossRef

53.

Scremin OU, Figoni SF, Norman K, Scremin AM, Kunkel CF, Opava-Rutter D et al (2010) Preamputation evaluation of lower-limb skeletal muscle perfusion with H ₂ ¹⁵ O positron emission tomography. Am J Phys Med Rehabil 89:473–486PubMedCrossRef

54.

Nawaz A, Saboury B, Basu S, Zhuang H, Moghadam-Kia S, Werner T et al (2012) Relation between popliteal-tibial artery atherosclerosis and global glycolytic metabolism in the affected diabetic foot: a pilot study using quantitative FDG-PET. J Am Podiatr Med Assoc 102:240–246PubMed

55.

Nolting DD, Nickels ML, Guo N, Pham W (2012) Molecular imaging probe development: a chemistry perspective. Am J Nucl Med Mol Imaging 2:273–306PubMed

56.

Beller GA, Sinusas AJ (1990) Experimental studies of the physiologic properties of technetium-99m isonitriles. Am J Cardiol 66:5E–8EPubMedCrossRef

57.

Bostrom PA, Diemer H, Leide S, Lilja B, Bergqvist D (1993) ^99mTc-sestamibi uptake in the leg muscles and in the myocardium in patients with intermittent claudication. Angiology 44:971–976PubMedCrossRef

58.

Hamanaka D, Odori T, Maeda H, Ishii Y, Hayakawa K, Torizuka K (1984) A quantitative assessment of scintigraphy of the legs using ²⁰¹Tl. Eur J Nucl Med 9:12–16PubMedCrossRef

59.

Kusmierek J, Dabrowski J, Bienkiewicz M, Szuminski R, Plachcinska A (2006) Radionuclide assessment of lower limb perfusion using ^99mTc-MIBI in early stages of atherosclerosis. Nucl Med Rev Cent East Eur 9:18–23PubMed

60.

Miles KA, Barber RW, Wraight EP, Cooper M, Appleton DS (1992) Leg muscle scintigraphy with ^99mTc-MIBI in the assessment of peripheral vascular (arterial) disease. Nucl Med Commun 13:593–603PubMed

61.

Forrest I, Hayes G, Smith A, Yip TC, Walker PM (1989) Identification of clinically significant skeletal muscle necrosis by single photon emission computed tomography. Can J Surg 32:109–112PubMed

62.

Yip TC, Houle S, Tittley JG, Walker PM (1992) Quantification of skeletal muscle necrosis in the lower extremities using ^99mTc pyrophosphate with single photon emission computed tomography. Nucl Med Commun 13:47–52PubMedCrossRef

63.

Bajnok L, Kozlovszky B, Varga J, Antalffy J, Olvaszto S, Fulop T Jr (1994) Technetium-99m sestamibi scintigraphy for the assessment of lower extremity ischaemia in peripheral arterial disease. Eur J Nucl Med 21:1326–1332PubMedCrossRef

64.

Dobrucki LW, Sinusas AJ (2010) PET and SPECT in cardiovascular molecular imaging. Nat Rev Cardiol 7:38–47PubMedCrossRef

65.

Wu AM (2009) Antibodies and antimatter: the resurgence of immuno-PET. J Nucl Med 50:2–5PubMedCrossRef

66.

Wu AM, Senter PD (2005) Arming antibodies: prospects and challenges for immunoconjugates. Nat Biotechnol 23:1137–1146PubMedCrossRef

67.

Zhang Y, Hong H, Engle JW, Yang Y, Theuer CP, Barnhart TE et al (2012) Positron emission tomography and optical imaging of tumor CD105 expression with a dual-labeled monoclonal antibody. Mol Pharm 9:645–653PubMedCrossRef

68.

Hong H, Severin GW, Yang Y, Engle JW, Zhang Y, Barnhart TE et al (2012) Positron emission tomography imaging of CD105 expression with ⁸⁹Zr-Df-TRC105. Eur J Nucl Med Mol Imaging 39:138–148PubMedCrossRef

69.

Zhang Y, Hong H, Engle JW, Bean J, Yang Y, Leigh BR et al (2011) Positron emission tomography imaging of CD105 expression with a ⁶⁴Cu-labeled monoclonal antibody: NOTA is superior to DOTA. PLoS One 6:e28005PubMedCrossRef

70.

Engle JW, Hong H, Zhang Y, Valdovinos HF, Myklejord DV, Barnhart TE et al (2012) Positron emission tomography imaging of tumor angiogenesis with a ⁶⁶Ga-labeled monoclonal antibody. Mol Pharm 9:1441–1448PubMedCrossRef

71.

Dallas NA, Samuel S, Xia L, Fan F, Gray MJ, Lim SJ et al (2008) Endoglin (CD105): a marker of tumor vasculature and potential target for therapy. Clin Cancer Res 14:1931–1937PubMedCrossRef

72.

Zhang Y, Yang Y, Hong H, Cai W (2011) Multimodality molecular imaging of CD105 (Endoglin) expression. Int J Clin Exp Med 4:32–42PubMed

73.

Helisch A, Wagner S, Khan N, Drinane M, Wolfram S, Heil M et al (2006) Impact of mouse strain differences in innate hindlimb collateral vasculature. Arterioscler Thromb Vasc Biol 26:520–526PubMedCrossRef

74.

Tirziu D, Moodie KL, Zhuang ZW, Singer K, Helisch A, Dunn JF et al (2005) Delayed arteriogenesis in hypercholesterolemic mice. Circulation 112:2501–2509PubMedCrossRef

75.

Saucy F, Dischl B, Delachaux A, Feihl F, Liaudet L, Waeber B et al (2006) Foot skin blood flow following infrainguinal revascularization for critical lower limb ischemia. Eur J Vasc Endovasc Surg 31:401–406PubMedCrossRef

76.

Murohara T, Asahara T, Silver M, Bauters C, Masuda H, Kalka C et al (1998) Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest 101:2567–2578PubMedCrossRef

Titel: PET/SPECT imaging of hindlimb ischemia: focusing on angiogenesis and blood flow
verfasst von: Hakan Orbay
Hao Hong
Yin Zhang
Weibo Cai
Publikationsdatum: 01.04.2013
Verlag: Springer Netherlands
Erschienen in: Angiogenesis / Ausgabe 2/2013
Print ISSN: 0969-6970
Elektronische ISSN: 1573-7209
DOI: https://doi.org/10.1007/s10456-012-9319-4

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Das Risiko für Vorhofflimmern in der Bevölkerung steigt

02.05.2024 Vorhofflimmern Nachrichten

Das Risiko, im Lauf des Lebens an Vorhofflimmern zu erkranken, ist in den vergangenen 20 Jahren gestiegen: Laut dänischen Zahlen wird es drei von zehn Personen treffen. Das hat Folgen weit über die Schlaganfallgefährdung hinaus.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2013

High-fat feeding induces angiogenesis in skeletal muscle and activates angiogenic pathways in capillaries

High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC)

Identification of soluble CD146 as a regulator of trophoblast migration: potential role in placental vascular development

Therapeutic potential of nitric oxide donors in the prevention and treatment of angiogenesis-inhibitor-induced hypertension

The stem cell marker prominin-1/CD133 interacts with vascular endothelial growth factor and potentiates its action